ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011

In Brief: David Tweardy named head of internal medicine at MD Anderson

September 19, 2014

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

April 25, 2013

White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.

July 28, 2000

NCI AIDS Malignancy Bank Accepts Requests; RFA Available

December 1, 1995

ACS Did Not Sign Bumpers Letter

May 1, 1992